A double-blind, randomized, crossover assessment of blood pressure following administration of avitriptan, sumatriptan, or placebo to patients with mild to moderate hypertension.

Abstract

We examined the effects of avitriptan, a 5-hydroxytryptamine 1-like (5HT1) receptor agonist for the treatment of migraine, in patients with medicated, controlled, mild to moderate hypertension relative to placebo and sumatriptan. The study was randomized, double-blinded, placebo-controlled, and 4-way crossover in design. Twenty patients (12M, 8F… (More)

Topics

Cite this paper

@article{Jhee1999ADR, title={A double-blind, randomized, crossover assessment of blood pressure following administration of avitriptan, sumatriptan, or placebo to patients with mild to moderate hypertension.}, author={Stanford S Jhee and D. E. Salazar and Nathalie Ford and I Edgar Fulmor and John J. Sramek and Natalie Cutler}, journal={Cephalalgia : an international journal of headache}, year={1999}, volume={19 2}, pages={95-9} }